Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples